
Alembic Pharma shares surge 16%; here's why
According to the exchange filing, DSP Healthcare fund, which was launched by DSP Mutual Fund, acquired 36,276 shares in Alembic Pharma to hike its stake in the company to 5.01%.
According to the exchange filing, DSP Healthcare fund, which was launched by DSP Mutual Fund, acquired 36,276 shares in Alembic Pharma to hike its stake in the company to 5.01%.
The drug will be manufactured at Lupin’s Pithampura plant in India, says the company.
Glenmark has launched Zita‐PioMet, India’s first triple fixed-dose combination for high insulin‐resistant type 2 diabetes.
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.